Growing Cannabis Sector Sees Surge in Acquisitions

CannabisNewsWire Editorial Coverage: The ongoing growth of the cannabis sector is now driving a surge in acquisitions, as companies compete to control a burgeoning market.

The cannabis sector has seen incredible growth, reaching $10 billion this year in the United States alone.
This has led to a wave of mergers and acquisitions, as companies strengthen their positions.
This pattern is accompanied by expansion into new markets and investment in smaller companies by their larger cousins.

Hydroponic supplier Sugarmade, Inc. (OTCQB: SGMD) (SGMD Profile) is in the process of acquiring two hydroponic companies, improving its already strong position as a provider of vital cultivation equipment. Industry leader Aphria, Inc. (OTCQB: APHQF) is making acquisitions in Jamaica, Latin America, and Canada, with the latter giving it access to European markets. Cannabis outsider Constellation Brands, Inc. (NYSE: STZ) has invested heavily in cannabis grower Canopy Growth, with an eye to creating cannabis-infused beverages. In Florida, MedMen Enterprises, Inc. (OTCQB: MMNFF) has acquired cultivation and retail assets, expanding its reach from three to four states. And Emerald Health Therapeutics (OTCQX: EMHTF) is set to acquire the remaining shares of Northern Vine Canada Inc., in a move that gives Emerald full ownership of Northern Vine.

To view an infographic of this editorial, click here.

Acquisitions Heating Up in the Cannabis Sector

For a new sector of the economy, the cannabis industry has grown at a fantastic rate. In the relatively few years since medical cannabis started to be legalized in North America, a multimillion-dollar industry has evolved, covering cultivators, retailers, marketing and all the support services the industry needs. The recent legalization of recreational cannabis in several U.S. states and Canada, together with the growing popularity of medical cannabis, is propelling the industry’s value into the billions.

Initially, growth was mostly driven by the creation of new companies or subsidiaries of pharmaceutical firms, as they set up new businesses in a new economic space. But in recent years, that has changed. Larger cannabis companies have started taking over smaller rivals and companies serving different parts of the market. Acquisitions are on the rise.

Consolidation in a Growing Sector

The cannabis sector is made up of a wide range of companies, from those focused on cultivation to the likes of Sugarmade, Inc. (OTCQB: SGMD), a hydroponics supply company that is making a move into the broader cannabis space.

The appearance of this range of companies has been made possible by the phenomenal growth of the market. The cannabis market in the United States is expected to be worth over $10 billion this year, 50 percent larger than it was in 2016, and that growth shows no sign of slowing. With an estimated $46 billion worth of business still existing outside legal markets, there’s vast scope for expansion as legalization spreads and consumers are drawn away from black market dealers. And that’s only in the United States, never mind the rest of the world.

As faith in the industry grows, investors are pouring in additional funding, leading to a boom in mergers and acquisitions. Some early players are cashing out, making the most of their companies’ growth to make a healthy profit and move on to something new. Others are taking over these smaller businesses, creating businesses with greater economic clout and more vertical integration.

This led to 145 mergers and acquisitions in the sector in the first half of 2018, compared with only 79 during the same period a year before. Some of these have made big news, with Aphria investing $200 million acquisitions in Latin America and Jamaica while drinks company Constellation Brands acquired a third of the equity in Canopy Growth. This shift creates even more opportunities for companies sticking in the sector, such as Sugarmade.

Acquisitions Big and Small

Based in California, Sugarmade has immediate access to one of the world’s largest legal cannabis markets and is making the most of that. One of the largest publicly traded hydroponic supply companies, its growth has been fueled by the vital role hydroponic equipment plays in the cultivation of cannabis.

Much cannabis cultivation takes place indoors, using sophisticated specialist equipment produced by companies such as Sugarmade. This gives producers greater control over growing conditions, encourages more successful crops, allows year-round production and makes it easier to secure this valuable crop.

Already a significant supplier of hydroponics, Sugarmade looks set to consolidate its position through the recently announced acquisition of two companies selling hydroponic and other cultivation supplies. This could make a huge difference to the company’s financial fortunes. Its projected revenues for 2019, previously set at $30 million, could exceed $75 million if these deals go through, more than doubling the company’s revenues.

“The hydroponic supply sector is still highly fragmented with many of the larger players not likely to reach public company liquidity events for the original entrepreneurial teams,” said Jimmy Chan, CEO of Sugarmade. “We have entered into talks with at least two of these companies for acquisition, which we believe will be highly accretive for common Sugarmade shareholders and additive to our already robust top line growth rate. We wanted to publicly disclose these discussions to ensure that all shareholders have equal access to our direction, thus our recent public filing.”

The company has set a special shareholder meeting October 10, creating an opportunity to establish more shares in the company and discuss the acquisitions. In a fast-growing sector such as cannabis, there’s little time for delay.

Investing in Others

Sugarmade’s success is largely driven by reaching new markets and supporting other companies, maximizing its potential for growth. Though U.S. based, the company has also begun expansion into the European market through online sales into the United Kingdom. Even in countries without a legal cannabis market, it is possible for hydroponics companies to sell their wares to people growing other specialist plants. And with cannabis legalization spreading globally, this allows companies such as Sugarmade to firmly establish their positions before a new market emerges.

The company is expanding its presence within the North American cannabis market by investing in industrial hemp and cannabidiol (CBD). Industrial hemp, a form of cannabis without the high, can be used for a wide range of purposes and looks set to be widely grown in the United States following the passage of the 2018 Farm Bill.

CBD, which can be derived from industrial hemp, is a chemical whose beneficial properties are only just starting to be understood and which is used in a growing range of health and wellness products. Sugarmade is investing $1 million Hempistry, Inc., a Nevada hemp company. This is expected to provide access to Hempistry shares as well as a supply agreement between the two companies.

Other businesses are also working to expand within the sector.

Aphria, Inc. (OTCQB: APHQF), one of the most successful companies in the cannabis sector, is undertaking acquisitions that will extend its reach beyond North America. In July, it announced acquisitions in Argentina, Colombia, and Jamaica worth around $200 million. Acquired through sister company Scythian Biosciences Corp., these will give Aphria reach into markets outside the United States and Canada. The company also expanded its international reach through the acquisition of Canadian company Nuuvera, which has supply and sales agreements with companies in Germany, Italy, Spain, Malta, the United Kingdom, Israel and Uruguay.

Drinks manufacturer Constellation Brands, Inc. (NYSE: STZ) is best known for beverages such as Corona, but it has recently made some surprising choices. The company has invested heavily in Canadian company Canopy Growth, moving into the cannabis market. Constellation’s approach isn’t about selling cannabis but about creating cannabis-infused drinks. These beverages are due to become legal in Canada next year. By creating a bridge between beverage manufacturers and cannabis growers, Constellation could be the first to establish widely recognized cannabis drink brands.

Cannabis manufacturer and retailer MedMen Enterprises, Inc. (OTCQB: MMNFF) shows what can be achieved by combining different elements in the cannabis supply chain. The company sees the product through from cultivation to customers’ hands, all under a carefully managed brand. This summer, it acquired dispensary and cultivation assets from Treadwell Simpson Partnership and affiliates, adding facilities in Florida to those it already owned in California, Nevada, and New York.

Emerald Health Therapeutics (OTCQX: EMHTF) owns Agro-Biotech, a licensed cannabis grower with a 75,000-square-foot indoor facility and plans to add a 500,000-square foot greeQnhouse. The company also owns 50 percent of Pure SunFarms, which is converting a licensed existing 1.1 million-square-foot greenhouse into a full-production commercial resource.

The cannabis sector has matured in recent years. As it grows within the United States and beyond, acquisitions are allowing companies to expand their options and strengthen their position in a powerful new industry.

For more information on Sugarmade, visit Sugarmade, Inc. (OTCQB: SGMD)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Canadian Cannabis Legalization Set to Transform the Industrial Hemp Industry

CannabisNewsWire Editorial Coverage: The legalization of cannabis in Canada is about to bring big changes not just for medical cannabis companies but for hemp growers as well.

The law legalizing recreational cannabis in Canada will come into force on October 17.
This will create new opportunities for hemp growers to produce the plant for CBD extraction.
Hemp growers will now be able to profit from all parts of the plant.
Cannabis companies are experimenting with growing techniques, expanding their businesses, and seeking supply agreements in preparation for the change.

Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile), which grows industrial hemp in Canada, will now be able to sell leaves and flowers as well as other parts of its plants, and is preserving this year’s crop in preparation for the change. In the United States, Isodiol International, Inc. (OTC: ISOLF) is raising the profile of the industry through a celebrity partnership and the expansion of its retail chain. Aurora Cannabis, Inc. (OTC: ACBFF) has been acquiring financing to fund a program of expansions and takeovers, preparing the way to dominate the American market. Organigram Holdings, Inc. (OTC: OGRMF) and Emerald Health Therapeutics (OTC: EMHTF) have both set up a string of supply agreements, giving them quick access to the Canadian recreational market come October.

To view an infographic of this editorial, click here.

Transforming Canada’s Cannabis Industry

On October 17, cannabis will become legal in Canada. Under the provisions of the Cannabis Act, Canadians will be able to buy and consume cannabis for recreational as well as medical purposes. Careful licensing, together with clear rules around cultivation and processing, will ensure that a previously illegal industry becomes a well-regulated part of the legal economy. As Prime Minister Trudeau said when the law was passed, “It’s been too easy for our kids to get marijuana — and for criminals to reap the profits. Today, we change that.”

The Cannabis Act promises to be a great boon to the Canadian economy. Since 2014, the Canadian medical cannabis industry has grown to include over 100 licensed companies, many of which will be able to expand their sales and research under the new rules. In a year’s time, further rules will come into force that allow the sale of concentrates and edible cannabis products, creating a cannabis food and drink industry. But one of the biggest changes will take place within the industrial hemp industry.

Cannabis without the High

While the term “cannabis” is most often used to refer to plants with psychoactive effects, it actually covers a broader range of crops. One of the most historically prevalent varieties of cannabis is industrial hemp, a form of cannabis grown by companies such as the Marijuana Company of America (OTC: MCOA).

Industrial hemp is distinct from more controversial forms of cannabis — marijuana — in that it does not contain tetrahydrocannabinol (THC), the active ingredient that gets users high, but rather it contains cannabidiol (CBD), which has recently grown in popularity due to its variety of medicinal benefits. Hemp was used for hundreds of years to produce fibers for cloth and rope and was widely grown in North America. But for most of the past century, it has been out of production thanks to broad-ranging anti-cannabis legislation.

The past few years have seen a resurgence for industrial hemp. Legislation created for the cultivation of medical marijuana has created the opportunity for companies such as MCOA to grow hemp in Canada. In the United States, the 2014 Farm Bill created legal space for trial crops of hemp. That bill’s 2018 successor appears set to make it entirely legal in the United States, allowing farmers to grow a highly profitable new crop.

The passing of the Cannabis Act will further improve the potential of hemp in Canada, as it will allow producers to extract cannabidiol (CBD). Cannabidiol is an active ingredient that’s commonly found in high concentrations in certain varieties of industrial hemp. It doesn’t have the psychoactive properties of THC but has been shown to have beneficial effects on health. As a result, it’s used in a growing variety of health and wellness products, including MCOA’s brand hempSMART.

Using the Whole Plant

Up until now, Canadian hemp producers have been limited in what they can do with the plant. The seeds could be extracted and used; fibers could be turned into textiles; and leftover elements known as hurds could be turned into either animal feed or construction materials. The use of leaves and flowers was specifically prohibited.

The Cannabis Act allows for a broader range of uses. Health Canada has proposed the introduction of new industrial hemp licenses to make this a reality. Under the proposed system, industrial hemp producers will be able to sell the whole plant or any of its parts to other licensed operators within the hemp industry. They could even process it themselves, extracting CBD oil as well as seeds, fibers and hurds.

It’s a change that will create a more efficient and profitable industry, as parts of the plant will no longer go to waste. And growing interest in CBD as a wellness ingredient could lead to a significant rise in income for hemp farmers. Companies such as MCOA, whose operations cover the whole industrial chain from hemp production to the sale of CBD products, will be able to build solid, sustainable supply chains that maximize profits at every step.

This is all before taking into account the possibility of agricultural subsidies. There is currently disagreement within Canada over whether cannabis growers will be eligible for subsidies under existing rules, but with the arrival of cannabis-based foods and beverages next year, lines will become increasingly blurry. MCOA and its joint venture partner, Global Hemp Group Inc., have received financial support from Canadian government agencies to research hemp cultivation. As the commercial landscape changes, hemp producers may soon find themselves eligible for even more government help.

Sowing the Seeds for a Growing Industry

MCOA’s growth in the Canadian hemp sector comes through its establishment of a high-yielding CBD hemp cultivation project in New Brunswick (NB). This collaboration with Global Hemp Group has revived hemp cultivation in the region 20 years after a previous effort failed.

The joint venture partners are in process of completion of the first phase of what is known as the Hemp Agro-Industrial Zone, or HAIZ. The aim of the HAIZ is to provide a steady supply of hemp by building a local industrial cluster, guaranteeing a market for farmers and leading to year-round jobs for others in the region. Through trial crops and careful measurement of the results, the project is providing valuable data on important issues such as pests, fertilizers and growth rates.

Recent developments at the site include the installation of drying equipment in preparation for processing. In the short term, this will allow the company to effectively store its current harvest until it can be sold and processed under the rules coming in October. In the longer term, it will increase its options for growing, processing and selling hemp. The joint venture partners are currently in the process of negotiating off-take agreements with extraction companies to sell the biomass produced during the October harvest in New Brunswick.

MCOA and its partners in New Brunswick have been finding ingenious ways to improve techniques impeded by decades outside the law. This year, the team in NB experimented with a modified bean harvester to strip leaves and flowers from the plants without picking up much straw. Based on the results, this technique is being extended to the entire 125-acre project.

Cannabis Cultivation Creates New Industry

In less than two decades, a whole new industry has grown up around the cultivation of hemp and other forms of cannabis. Even with restrictions still tight in much of the world, companies are finding ways to legally profit from these crops.

Isodiol International, Inc. (OTC: ISOLF) has become an important and active voice for the industry, employing former NFL player Marvin Washington as a director and spokesperson. The company has developed a variety of cannabis and CBD-derived products, tapping into the medical and vaping markets. Its KURE Corp subsidiary provides a strong retail front and has recently set its sights on further expansion through new and acquired shops.

A prominent player within the industry, Aurora Cannabis, Inc. (OTC: ACBFF) is making the most of a young market to rapidly expand its business. A $150 million loan from the Bank of Montreal is giving it a short-term financial boost to get ahead of the long-term game. It’s this sort of long-term thinking that has led the company to acquisitions such as the takeover of MedReleaf, increasing Aurora’s market share. Some commentators have compared this strategy with that of Amazon, focusing on market dominance as the route to profit.

Organigram Holdings, Inc. (OTC: OGRMF), a medical cannabis company, is preparing to expand into Canada’s recreational market in October. The company has established a number of agreements with other companies, most recently the Nova Scotia Liquor Corporation, to supply its products to stores. These agreements will ensure that the legal recreational market quickly grows from a principle to a reality.

Emerald Health Therapeutics (OTC: EMHTF) is also setting up supplier agreements to give it a place in the recreational starting lineup. Its partners include the Newfoundland Labrador Liquor Corporation and Ontario Cannabis Retail Corporation.

The Canadian cannabis industry is set to experience a transformation on October 17, one that will prepare companies to expand as laws change elsewhere in the world. From medical cannabis companies to hemp growers, many business enterprises are likely to profit from this change.

For more information on Marijuana Company of America, visit Marijuana Company of America, Inc. (OTC: MCOA)